世界の医療用マリファナ市場2022-2029:製剤種類別(カプセル、オイル、その他)、用途別、地域別

【英語タイトル】Global Medical Marijuana Market Size study & Forecast, by Formulation Type (Capsules, Oils, and Other Formulation Types) by Application (Chronic Pain, Arthritis, Migraine, Cancer, and Other Applications) and Regional Analysis, 2022-2029

Bizwit Research & Consultingが出版した調査資料(BZW22DV139)・商品コード:BZW22DV139
・発行会社(調査会社):Bizwit Research & Consulting
・発行日:2022年11月30日
・ページ数:約200
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥732,600見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥925,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Bizwit Research社は、2021年におよそ110億ドルであった世界の医療用マリファナ市場規模が、2022年から2029年の間に21.06%以上成長すると予測しています。当調査資料は、医療用マリファナの世界市場を総合的に調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、リスク分析(新型コロナウイルス感染症の影響)、製剤種類別(カプセル、オイル、その他)分析、用途別(慢性疼痛、関節炎、片頭痛、がん、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、その他地域)分析、競争分析、調査プロセスなど、以下の構成でまとめております。なお、当書には、Tilray、Aurora Cannabis、Canopy Growth Corporation、Aphria, Inc.、Maricann Group, Inc.、Tikun Olam, Ltd.、MedReleaf. Corp.、GW Pharmaceuticals plc.、Cannabis Sativa, Inc.、Medical Marijuana, Inc.などの企業情報が含まれています。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・リスク分析(新型コロナウイルス感染症の影響)
・世界の医療用マリファナ市場規模:製剤種類別
- カプセルの市場規模
- オイルの市場規模
- その他製剤の市場規模
・世界の医療用マリファナ市場規模:用途別
- 慢性疼痛における市場規模
- 関節炎における市場規模
- 片頭痛における市場規模
- がんにおける市場規模
- その他用途における市場規模
・世界の医療用マリファナ市場規模:地域別
- 北米の医療用マリファナ市場規模
- ヨーロッパの医療用マリファナ市場規模
- アジア太平洋の医療用マリファナ市場規模
- 中南米の医療用マリファナ市場規模
- その他地域の医療用マリファナ市場規模
・競争分析
・調査プロセス

Global Medical Marijuana Market is valued approximately at USD 11.0 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 21.06% over the forecast period 2022-2029. Medical marijuana, also referred to as medical cannabis, is derived from the Cannabis sativa plant which is also used to treat a disease or specific symptom such as cancer, chronic pain, mental disorders, and manage pain. Cannabis Sativa and Cannabis Indica, which come from the western hemisphere and central and south Asian regions, respectively, are the two types of medical marijuana. The key factors driving the market growth is rising awareness about benefits of medical marijuana, growing legalization of cannabis across region and growing FDA approvals for medicinal cannabis products.

In 2018, FDA approved the first drug comprising of an active component derived from marijuana for treating epilepsy. Epidiolex (cannabidiol) [CBD] in oral solution was granted this approval to treat seizures related to two severe and rare forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome. In January 2018, the Australian Government allowed marijuana producers in the country to export medical marijuana and its products to the global medical marijuana market. Also, innovative product development with growing R&D activities will create lucrative opportunities for the market during forecast period. However, the complex regulatory structure for the usage of cannabis stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Medical Marijuana Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the rising cannabis legalization in the U.S. This is one of the key factors contributing to its growing demand. Asia Pacific is also anticipated to exhibit highest growth rate over the forecast period, owing to factors such as increasing legalization of cannabis as well as an increase in disposable income, social acceptance, and consumer understanding of the product’s advantages.

Major market player included in this report are:
Tilray
Aurora Cannabis
Canopy Growth Corporation
Aphria, Inc.
Maricann Group, Inc.
Tikun Olam, Ltd.
MedReleaf. Corp.
GW Pharmaceuticals plc.
Cannabis Sativa, Inc.
Medical Marijuana, Inc.

Recent Developments in the Market:
 In Feb. 2022, Bombay Hemp Company, an agro company, joined along with Poonthottam Ayurvedasram to utilize the medicinal properties of cannabis for modern use. Asia’s first Ayurvedic Cannabis Wellness Retreat is a partnership under the name “AyurCann: Ayurvedic Cannabis Therapies.”
 In April 2022, MediCane Health Inc. and Dr. Reddy’s Laboratories Ltd. introduced their medicinal marijuana product in Germany.

Global Medical Marijuana Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Formulation Type, Application, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Formulation Type:
Capsules
Oils
Other Formulation Types

By Application:
Chronic Pain
Arthritis
Migraine
Cancer
Other Applications

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

❖ レポートの目次 ❖

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Medical Marijuana Market, by region, 2019-2029 (USD Billion)
1.2.2. Medical Marijuana Market, by Formulation Type, 2019-2029 (USD Billion)
1.2.3. Medical Marijuana Market, by Application, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Medical Marijuana Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Medical Marijuana Market Dynamics
3.1. Medical Marijuana Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising Awareness about benefits of medical marijuana
3.1.1.2. Growing legalization of cannabis
3.1.2. Market Challenges
3.1.2.1. Complex regulatory structure for the usage of cannabis
3.1.3. Market Opportunities
3.1.3.1. Innovative product development with growing R&D activities
Chapter 4. Global Medical Marijuana Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economic
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Medical Marijuana Market, by Formulation Type
6.1. Market Snapshot
6.2. Global Medical Marijuana Market by Formulation Type, Performance – Potential Analysis
6.3. Global Medical Marijuana Market Estimates & Forecasts by Formulation Type 2019-2029 (USD Billion)
6.4. Medical Marijuana Market, Sub Segment Analysis
6.4.1. Capsules
6.4.2. Oils
6.4.3. Other Formulation Types
Chapter 7. Global Medical Marijuana Market, by Application
7.1. Market Snapshot
7.2. Global Medical Marijuana Market by Application, Performance – Potential Analysis
7.3. Global Medical Marijuana Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
7.4. Medical Marijuana Market, Sub Segment Analysis
7.4.1. Chronic Pain
7.4.2. Arthritis
7.4.3. Migraine
7.4.4. Cancer
7.4.5. Other Applications
Chapter 8. Global Medical Marijuana Market, Regional Analysis
8.1. Medical Marijuana Market, Regional Market Snapshot
8.2. North America Medical Marijuana Market
8.2.1. U.S. Medical Marijuana Market
8.2.1.1. Formulation Type breakdown estimates & forecasts, 2019-2029
8.2.1.2. Application breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Medical Marijuana Market
8.3. Europe Medical Marijuana Market Snapshot
8.3.1. U.K. Medical Marijuana Market
8.3.2. Germany Medical Marijuana Market
8.3.3. France Medical Marijuana Market
8.3.4. Spain Medical Marijuana Market
8.3.5. Italy Medical Marijuana Market
8.3.6. Rest of Europe Medical Marijuana Market
8.4. Asia-Pacific Medical Marijuana Market Snapshot
8.4.1. China Medical Marijuana Market
8.4.2. India Medical Marijuana Market
8.4.3. Japan Medical Marijuana Market
8.4.4. Australia Medical Marijuana Market
8.4.5. South Korea Medical Marijuana Market
8.4.6. Rest of Asia Pacific Medical Marijuana Market
8.5. Latin America Medical Marijuana Market Snapshot
8.5.1. Brazil Medical Marijuana Market
8.5.2. Mexico Medical Marijuana Market
8.6. Rest of The World Medical Marijuana Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Tilray
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Aurora Cannabis
9.2.3. Canopy Growth Corporation
9.2.4. Aphria, Inc.
9.2.5. Maricann Group, Inc.
9.2.6. Tikun Olam, Ltd.
9.2.7. MedReleaf. Corp.
9.2.8. GW Pharmaceuticals plc.
9.2.9. Cannabis Sativa, Inc.
9.2.10. Medical Marijuana, Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption



★調査レポート[世界の医療用マリファナ市場2022-2029:製剤種類別(カプセル、オイル、その他)、用途別、地域別] (コード:BZW22DV139)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の医療用マリファナ市場2022-2029:製剤種類別(カプセル、オイル、その他)、用途別、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆